Back

Association of AST/ALT ratio and 1-year mortality in older patients with acute decompensated heart failure

18 May 2025 (10:00 - 10:45)
Organised by: Logo
Congress Presentation Part of: Acute heart failure prognosis Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Le Phuong Thao Nguyen

TAM DUC HEART HOSPITAL, Ho Chi Minh (Viet Nam)

6 More presentations in this session

Presentation thumbnail
Red blood cell distribution width is a useful biomarker to predict prognosis in patients admitted for acute heart failure and with a preserved left ventricular ejection fraction
Doctor L. Sensini (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Hypoferremia reduces long-term risk of major adverse cardiovascular events after STEMI by averting the myocardial reactive iron storm
Associate Professor S. Lakhal-Littleton (Oxford, GB)
Abstract Slides Video
Presentation thumbnail
Prognostic impact of systolic blood pressure trajectory among patients hospitalized in an acute heart failure setting: insights from a real-world multicenter cohort
Mr M. Carminati (Lausanne, CH)
Abstract Slides Video
Presentation thumbnail
Short-term outcomes of acute heart failure patients hospitalized in internal medicine vs cardiology wards
Doctor G. Antonelli (Rozzano, IT)
Abstract Slides Video
Presentation thumbnail
The ABCDE score: a simple tool for predicting 3 month mortality in acute heart failure patients
Mr D. Inacio Cazeiro (Lisbon, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Acute heart failure prognosis

The Event

Event poster

Heart Failure 2025

18 May 2025 10:00 CET
You may be interested in
thumbnail
Congress Presentation
The AST to ALT ratio: a new predictor for left ventricular systolic dysfunction following ST segment myocardial infarction
thumbnail
Congress Presentation
Prognostic value of neutrophil percentage-to-albumin ratio in patients with acute decompensated heart failure
thumbnail
Congress Session
Contemporary biomarkers for diagnosis, monitoring, and prognosis in heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources